(Q83305347)
English
Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Gr
scientific article published on 26 January 2011
Statements
Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study (English)
Spilios Manolakopoulos
Giota Touloumi
Georgia Vourli
Maria Raptopoulou-Gigi
Irini Vafiadis-Zoumbouli
Kostas Mimidis
Charalambos Gogos
Ioannis Ketikoglou
Emanuel K Manesis
HEPNET. Greece Cohort Study Group